Search for: "Sanofi US Services Inc" Results 41 - 60 of 77
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/   Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog)   General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law… [read post]
21 May 2010, 2:32 am by gmlevine
Two recent examples of disclaimers bolstering bad faith are Sanofi-Aventis, Aventis Pharma SA, Aventis Pharmaceuticals Inc. v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
15 Sep 2009, 2:30 pm
" The vaccines are made by CSL Limited, MedImmune LLC, Novartis Vaccines and Diagnostics Limited, and sanofi pasteur Inc. [read post]
9 Apr 2009, 9:27 am
(IP Frontline)   US Patents Percentage of patents that were initially rejected (Patently-O) Design patents: Sailing through the PTO (Patently-O) Patents and the auto industry bailout (Patently-O) Tips for assisting the judge and jury in patent cases (IP Watchdog) US patent counts, Q1 2009 (Patent Librarian's Notebook) What good are patent method claims? [read post]
16 Jan 2009, 7:00 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
20 Dec 2008, 3:00 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
5 Sep 2008, 11:01 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Google Chrome EULA – Controversy over non-exclusive license clause permitting Google to use content submitted through the service: (IP Thinktank), (BriefBlog), (Copyfight), (Copyfight), (The Trademark Blog), (Public Knowledge), (Ars Technica), (IPKat), US presidential campaigns clash on patent law: (Out-Law),… [read post]
23 Aug 2008, 1:23 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
9 Aug 2008, 1:50 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge… [read post]
11 Jul 2008, 4:30 am
Please join the discussion by adding your comments on any of these stories, and please do let us know if you think we’ve missed something important, or if there is a source you think should be monitored. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade… [read post]